Real world evidence research breakfast seminar
We were delighted to attend and present a paper at the Tech Observer event in Singapore earlier this month
APAC Director Pei Li Teh, and Research Manager, Colin Tan, attended the event. Pei Li presented the paper ‘Inhale, exhale: How using real world data helped asthma patients breathe easier across Asia’. In her paper she demonstrated how published real world data research provided pharma companies with an in-depth understanding of asthma patients’ across Asia. The data provided the healthcare community with a tool to supply tailored communications supporting different patient types, instead of a ‘one size fits all’ approach.
Research Partnership welcomes Jeanne Penn
We are delighted to announce that Jeanne Penn has joined the Singapore office as a Senior Research Executive.
Jeanne previously worked at Cello Health Insight in New York City on the qualitative team, where she was involved in all parts of the research process, from writing proposals to delivering reports. She’s worked in various therapy areas, and has a particular interest in rare diseases and mental health. In a prior role, she co-led the first Diversity & Inclusion initiative and was awarded the Young Professionals Grant to attend the Qualitative Research Consultants Association (QRCA) conference. Jeanne graduated from Hamilton College, and interned at Hall & Partners where she was first introduced to healthcare market research.
How we helped our client understand current and future combination pricing strategies in the Multiple Myeloma market
Our client had their product for multiple myeloma (MM) approved in several lines of therapy combined with different backbones. Their product was also being studied in some other indications with additional backbones and was anticipated to receive approval in the coming years. With several other competitive therapies available on the market, including many branded combination products, our client anticipated that payers might start considering strategies to manage combination therapies in the future. Therefore, they wanted to understand what the current and future combination pricing strategies were for oncology products, with a focus on MM and their product.
How we helped assess the asthma market landscape in emerging markets
Our client was jointly developing a fully-human monoclonal antibody (mAB) with a number of potential immunological indications. In order to prepare for launch, primary and secondary market research was required to understand more fully the asthma landscape.
Conducting market research for scientific publication guide
Conducting and using market research for publication can be valuable for shaping opinions in healthcare. The findings can be used to influence existing perceptions, change current practices and behaviour in a particular disease area, and help both patients and physicians to make more informed decisions. Based on our expertise and experience of conducting market research for scientific publication in both developed and emerging markets across a wide range of therapy areas, we have put together a guide on how to establish medical credibility with your research.